Has Ankit Srivastava received payments from drug or device companies?

Yes. Drug and device makers reported $3,927 in general payments to Ankit Srivastava across 120 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ankit Srivastava did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ankit Srivastava come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ankit Srivastava

Family Medicine · Oakland Park, FLNPI 1225787955

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 120 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by Viiv Healthcare Company at 26.4% of the total. 2025 is the largest year on record at $3,162, more than ten times the $126 reported in 2023.

$3,927in general payments, 2019–2025

Across 120 payments — averaging $32.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Viiv Healthcare Company$1K
Gilead$728
Theratechnologies Inc.$254
Phathom Pharmaceuticals, Inc.$219
EMD Serono, Inc.$204
Novo Nordisk$195
plus $1K from 19 others

What the payments were for

Food & beverage$3,927100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Viiv Healthcare Company	27	$1,035
Gilead	26	$728
Theratechnologies Inc.	4	$254
Phathom Pharmaceuticals, Inc.	2	$219
EMD Serono, Inc.	4	$204
Novo Nordisk	6	$195
Amgen	9	$165
Lilly USA, LLC	5	$156
Aimmune Therapeutics, Inc.	2	$148
Madrigal Pharmaceuticals	1	$146
Merck	5	$139
Napo Pharmaceuticals Inc	3	$74
Axsome Therapeutics, Inc.	5	$67
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	3	$47
Otsuka America Pharmaceutical, Inc.	2	$42
AbbVie	2	$40
GSK	2	$38
Verity Pharmaceuticals Inc.	2	$38
Lundbeck LLC	2	$34
Exact Sciences	2	$33
AstraZeneca	2	$31
Dexcom, Inc.	1	$26
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$23
Abbott	1	$23
Pfizer	1	$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,927 in reported general payments places this provider in the 85th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida →

Other family medicine in Oakland Park

Noah LeeOakland Park$1.2M
Angela RosselotBelle Isle$977K
Richard LappOrlando$702K
Hal BrownVero Beach$477K
Lisa EvansBoca Raton$473K
Giovana Rene CrooksBoca Raton$407K
Edward BraunSt Petersburg$364K
Samuel GreenleePensacola$235K
Kevin FitzgeraldStuart$198K
Louis KuritzkyGainesville$186K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →